LANI completes Phase I in Japan and to commence Phase I in UK
27-Apr-2007 -
Biota Holdings Limited announced that its long acting neuraminidase inhibitor (LANI), CS8958, an anti-influenza treatment, has demonstrated effectiveness against the avian flu virus H5N1, completed Phase I studies in Japan and received ethics approval to commence comparable studies in the ...
avian influenza
clinical trials
Daiichi Sankyo
+5